A detailed history of Ambassador Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ambassador Advisors, LLC holds 7,098 shares of ABT stock, worth $726,338. This represents 0.15% of its overall portfolio holdings.

Number of Shares
7,098
Previous 4,961 43.08%
Holding current value
$726,338
Previous $546,000 47.62%
% of portfolio
0.15%
Previous 0.12%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $234,044 - $258,491
2,137 Added 43.08%
7,098 $806,000
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $3,337 - $4,084
-37 Reduced 0.74%
4,961 $546,000
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $75,277 - $90,320
788 Added 18.72%
4,998 $484,000
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $49,986 - $55,695
496 Added 13.35%
4,210 $458,000
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $359,738 - $423,433
3,714 New
3,714 $376,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ambassador Advisors, LLC Portfolio

Follow Ambassador Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ambassador Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ambassador Advisors, LLC with notifications on news.